INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 42h ago
HOUSE PTR2h ago
SEC 13F2h ago
ROBINHOOD CHAIN2h ago
SEC FORM 4/Open-market saleVerified dataRule 10b5-1 plan

Kao John E sold ALHC

Director, Chief Executive Officer · Alignment Healthcare, Inc. · Common Stock

Side
SELL
Value
$1.71M
Shares
82.3K
Price
$20.8
Executed
Apr 13, 2026
Disclosed
Apr 13, 2026
Disclosure timeline0 days from execution to publication · legal deadline 2 business days
Apr 13 executedApr 13, 2026 disclosed

ALHC · daily

Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.

Insider Score

Experimental signal
12/ 100 · ROUTINE
Methodology →
  • Transaction type+6 / 20

    Open-market sale

  • Relative size+10 / 25

    $1.7M reported value · 4.4% of prior position

  • Filing timing0 / 15

    Disclosed 0 business days after execution (deadline: 2)

  • Historical behavior+1 / 15

    Routine: 6 prior trades recorded in this security

  • Frequency & clustering+5 / 15

    1 other actor traded the same direction within 14 days

  • Market events0 / 10

    No material company filing within 60 days after the trade

  • Pre-arranged plan-10

    Executed under a Rule 10b5-1 trading plan

    • The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.

    Other disclosed activity · ALHC

    ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
    27
    KH
    Kim HyongChief Medical Officer
    ALHCAlignment Healthcare, Inc.
    Open-market sale
    		SELL$270K
    32.5K sh
    		Oct 6, 2026Oct 7, 2026
    traded Oct 6, 2026
    		+1dSEC FORM 4

    Evidence

    34
    KS
    Konowiecki Joseph SDirector, EVP, Corporate Affairs
    ALHCAlignment Healthcare, Inc.
    Open-market sale
    		SELL$202K
    23.5K sh
    		Sep 17, 2026Sep 18, 2026
    traded Sep 17, 2026
    		+1dSEC FORM 4

    Evidence

    40
    MC
    Maroney Dawn ChristinePresident
    ALHCAlignment Healthcare, Inc.
    Open-market sale
    		SELL$1.56M
    122.7K sh
    		Sep 11, 2026Sep 11, 2026
    traded Sep 11, 2026
    		+0dSEC FORM 4

    Evidence

    25
    KE
    Kao John EDirector, Chief Executive Officer
    ALHCAlignment Healthcare, Inc.
    Open-market sale · 10b5-1 plan
    		SELL$4.89M
    385.3K sh
    		Sep 11, 2026Sep 11, 2026
    traded Sep 11, 2026
    		+0dSEC FORM 4

    Evidence

    25
    KE
    Kao John EDirector, Chief Executive Officer
    ALHCAlignment Healthcare, Inc.
    Open-market sale · 10b5-1 plan
    		SELL$2.24M
    172.6K sh
    		Sep 10, 2026Sep 11, 2026
    traded Sep 10, 2026
    		+1dSEC FORM 4

    Evidence

    15
    KE
    Kao John EDirector, Chief Executive Officer
    ALHCAlignment Healthcare, Inc.
    Open-market sale · 10b5-1 plan
    		SELL$4.14M
    298.0K sh
    		Aug 10, 2026Aug 10, 2026
    traded Aug 10, 2026
    		+0dSEC FORM 4

    Evidence

    12
    MC
    Maroney Dawn ChristinePresident
    ALHCAlignment Healthcare, Inc.
    Open-market sale · 10b5-1 plan
    		SELL$626K
    30.0K sh
    		Apr 15, 2026Apr 15, 2026
    traded Apr 15, 2026
    		+0dSEC FORM 4

    Evidence

    12
    KE
    Kao John EDirector, Chief Executive Officer
    ALHCAlignment Healthcare, Inc.
    Open-market sale · 10b5-1 plan
    		SELL$295K
    13.8K sh
    		Apr 10, 2026Apr 13, 2026
    traded Apr 10, 2026
    		+3dSEC FORM 4

    Evidence

    19
    KE
    Kao John EDirector, Chief Executive Officer
    ALHCAlignment Healthcare, Inc.
    Open-market sale · 10b5-1 plan
    		SELL$4.16M
    201.9K sh
    		Apr 10, 2026Apr 13, 2026
    traded Apr 10, 2026
    		+3dSEC FORM 4

    Evidence

    19
    KE
    Kao John EDirector, Chief Executive Officer
    ALHCAlignment Healthcare, Inc.
    Open-market sale · 10b5-1 plan
    		SELL$59K
    2,727 sh
    		Jan 12, 2026Jan 14, 2026
    traded Jan 12, 2026
    		+2dSEC FORM 4

    Evidence

    29
    KE
    Kao John EDirector, Chief Executive Officer
    ALHCAlignment Healthcare, Inc.
    Open-market sale · 10b5-1 plan
    		SELL$3.74M
    177.3K sh
    		Jan 12, 2026Jan 14, 2026
    traded Jan 12, 2026
    		+2dSEC FORM 4

    Evidence

    49
    SL
    Scavo Robert L.Chief Information Officer
    ALHCAlignment Healthcare, Inc.
    Open-market sale
    		SELL$1.23M
    65.7K sh
    		Dec 29, 2025Dec 30, 2025
    traded Dec 29, 2025
    		+1dSEC FORM 4

    Evidence

    39
    SL
    Scavo Robert L.Chief Information Officer
    ALHCAlignment Healthcare, Inc.
    Open-market sale
    		SELL$74K
    3,813 sh
    		Dec 29, 2025Dec 30, 2025
    traded Dec 29, 2025
    		+1dSEC FORM 4

    Evidence

    49
    MC
    Maroney Dawn ChristinePresident
    ALHCAlignment Healthcare, Inc.
    Open-market sale
    		SELL$4.99M
    266.6K sh
    		Dec 29, 2025Dec 30, 2025
    traded Dec 29, 2025
    		+1dSEC FORM 4

    Evidence

    42
    MC
    Maroney Dawn ChristinePresident
    ALHCAlignment Healthcare, Inc.
    Open-market sale
    		SELL$300K
    15.5K sh
    		Dec 29, 2025Dec 30, 2025
    traded Dec 29, 2025
    		+1dSEC FORM 4

    Evidence

    42
    JJ
    Joyce Christopher JChief Legal and Admin. Officer
    ALHCAlignment Healthcare, Inc.
    Open-market sale
    		SELL$286K
    15.3K sh
    		Dec 29, 2025Dec 30, 2025
    traded Dec 29, 2025
    		+1dSEC FORM 4

    Evidence

    36
    JJ
    Joyce Christopher JChief Legal and Admin. Officer
    ALHCAlignment Healthcare, Inc.
    Open-market sale
    		SELL$17K
    888 sh
    		Dec 29, 2025Dec 30, 2025
    traded Dec 29, 2025
    		+1dSEC FORM 4

    Evidence

    39
    KH
    Kim HyongChief Medical Officer
    ALHCAlignment Healthcare, Inc.
    Open-market sale
    		SELL$224K
    12.0K sh
    		Dec 29, 2025Dec 30, 2025
    traded Dec 29, 2025
    		+1dSEC FORM 4

    Evidence

    36
    KH
    Kim HyongChief Medical Officer
    ALHCAlignment Healthcare, Inc.
    Open-market sale
    		SELL$13K
    696 sh
    		Dec 29, 2025Dec 30, 2025
    traded Dec 29, 2025
    		+1dSEC FORM 4

    Evidence

    56
    KE
    Kao John EDirector, Chief Executive Officer
    ALHCAlignment Healthcare, Inc.
    Open-market sale
    		SELL$10.71M
    572.4K sh
    		Dec 29, 2025Dec 30, 2025
    traded Dec 29, 2025
    		+1dSEC FORM 4

    Evidence

    Evidence

    Verified data

    Read directly from the primary public document; every field below is as reported by the filer.

    Source

    Document
    SEC Form 4
    Publisher
    U.S. Securities and Exchange Commission (EDGAR)
    Document ID
    0001628280-26-024978
    Machine-readable
    Structured copy

    Timestamps

    Event (reported)
    Apr 13, 2026
    Published
    Apr 13, 2026
    Ingested by INSIDER
    Nov 5, 04:05 UTC
    Last re-read
    Nov 5, 04:05 UTC

    Extracted facts

    Filer
    Kao John E
    Role
    Director, Chief Executive Officer
    Transaction
    Open-market saleAs filed: “S”
    Asset
    Alignment Healthcare, Inc.
    Ticker
    ALHC
    Shares
    82.3K
    Price per share
    $20.8
    Value
    $1,711,655
    Execution date (reported)
    Apr 13, 2026
    Owned after transaction
    1.81M shares
    Rule 10b5-1 plan
    Yes, as checked by the filer
    Days from execution to publication
    0

    Calculation

    Value = shares × reported price per share

    • Shares: 82.3K
    • Price: $20.798

    = $1,711,655

    What this establishes

    Kao John E filed this Form 4 reporting a open-market sale of ALHC on Apr 13, 2026. It became public on Apr 13, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

    Extraction

    Method
    Form 4 XML
    Confidence
    1.00
    Director, Chief Executive Officer
    Kao John Ecik:0001222028
    Issuer
    Alignment Healthcare, Inc.cik:0001832466

    Revision history · 0

    No field has changed since this record was first ingested.

    Company events

    No records

    No material filings recorded for this issuer.